Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

Published:2010-12 Issue:6 Volume:12 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Akhoondi Shahab,Lindström Linda,Widschwendter Martin,Corcoran Martin,Bergh Jonas,Spruck Charles,Grandér Dan,Sangfelt Olle

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2788.pdf

Reference53 articles.

1. Tan Y, Sangfelt O, Spruck C: The Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Lett. 2008, 271: 1-12. 10.1016/j.canlet.2008.04.036.

2. Welcker M, Clurman BE: FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2008, 8: 83-93. 10.1038/nrc2290.

3. Orlicky S, Tang X, Willems A, Tyers M, Sicheri F: Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell. 2003, 112: 243-256. 10.1016/S0092-8674(03)00034-5.

4. Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, Mueller-Holzner E, Corcoran M, Dagnell M, Nejad SZ, Nayer BN, Zali MR, Hansson J, Egyhazi S, Petersson F, Sangfelt P, Nordgren H, Grander D, Reed SI, Widschwendter M, Sangfelt O, Spruck C: FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007, 67: 9006-9012. 10.1158/0008-5472.CAN-07-1320.

5. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP: Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell. 2007, 26: 131-143. 10.1016/j.molcel.2007.02.022.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. The FBXW7-binding sites on FAM83D are potential targets for cancer therapy;Breast Cancer Research;2024-03-07

3. Epigenetic biomarkers in personalized medicine;Personalized Epigenetics;2024

4. FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1;Gastric Cancer;2023-12-24

5. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies;Frontiers in Pharmacology;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3